Real-World Data for 8 mg Aflibercept

Vasileios Konidaris, MD, PhD

Show Description +

Dr. Konidaris highlights early data from the SPECTRUM trial, the first global real-world study of 8 mg aflibercept (Eylea HD, Regeneron) in patients with treatment-naïve wet AMD.

Posted: 5/17/2025

Keywords:

retina-meeting-recap

•

aflibercept

•

Regeneron Pharmaceuticals

•

eylea hd

•

Eylea

•

Clinical Trials

•

treatment naive

•

Wet AMD

•

Age-Related Macular Degeneration (AMD)

Up Next

Name: Real-World Data for 8 mg Aflibercept
Uploaded: 2025-05-17T17:10:35+00:00
Description: Dr. Konidaris highlights early data from the SPECTRUM trial, the first global real-world study of 8 mg aflibercept (Eylea HD, Regeneron) in patients with treatment-naïve wet AMD.

$The Benefits of Refractive Vitrectomy for SVOs$

The Benefits of Refractive Vitrectomy for SVOs

Paulo Eduardo Stanga, MD

Bariatric Surgery Versus GLP-1 Receptor Agonists

Christabel Chan, MD

Treating DR with Axitinib

Neal S. Shah, MD

Phase 2 Data on Gene Therapy for AMD

Christine Kay, MD

OCS-01 (Oculis) in DME: A Phase 3 Update

Carl Danzig, MD

Gene Therapy for Wet AMD: New Phase 2 Data

Dante Pieramici MD

Surgical Pearls for Sickle Cell Retinopathy

Jennifer I. Lim, MD

Dosing Considerations with 8 mg Aflibercept

Mark R. Barakat, MD

Pegcetacoplan in the Real World: Year 1

Mengxi Shen, MD, PhD

Phase 2a Data Revealed for AVD-104 (Aviceda)

Baruch D. Kuppermann, MD, PhD

Back to All Videos

Real-World Data for 8 mg Aflibercept

Vasileios Konidaris, MD, PhD

Dr. Konidaris highlights early data from the SPECTRUM trial, the first global real-world study of 8 mg aflibercept (Eylea HD, Regeneron) in patients with treatment-naïve wet AMD.

Posted: 5/17/2025

Keywords:

retina-meeting-recap

•

aflibercept

•

Regeneron Pharmaceuticals

•

eylea hd

•

Eylea

•

Clinical Trials

•

treatment naive

•

Wet AMD

•

Age-Related Macular Degeneration (AMD)

Please log in to leave a comment.

Meeting Coverage:

Association for Research in Vision & Ophthalmology

Real-World Data for 8 mg Aflibercept

Up Next

Real-World Data for 8 mg Aflibercept

More From ARVO: 2025 Coverage